Pediatrix Medical Group, Inc. (MD) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 215.42M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215.42M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $218.37M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $208.81M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $199.31M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $165.09M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $-52.50M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $-68.71M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $-219.49M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $-213.05M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $-6.83M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $7.32M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $154.85M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $161.96M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $163.62M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $172.69M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $204.66M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $216.06M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $215.92M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $202.92M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $167.22M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $128.88M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $113.43M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $98.13M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $-1.20B | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $-1.20B | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $-1.20B | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-1.14B | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $-1.08B | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $382.75M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $424.64M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $445.85M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $467.98M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $485.25M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $478.47M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $480.08M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $497.15M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $527.61M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $553.49M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $571.69M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $579.87M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $574.11M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $567.28M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $557.87M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $547.99M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $535.01M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $523.72M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $513.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $495.83M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $480.98M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $464.68M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $452.13M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $431.24M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $415.32M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $401.68M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $389.52M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $378.01M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $365.67M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $359.06M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $355.39M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $349.77M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $336.10M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $325.08M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $312.91M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $288.93M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $242.03M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |